These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19221688)

  • 1. Treating liver cirrhosis in dogs with hepatocyte growth factor gene therapy via the hepatic artery.
    Horiguchi K; Hirano T; Ueki T; Hirakawa K; Fujimoto J
    J Hepatobiliary Pancreat Surg; 2009; 16(2):171-7. PubMed ID: 19221688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination gene therapy of HGF and truncated type II TGF-beta receptor for rat liver cirrhosis after partial hepatectomy.
    Ozawa S; Uchiyama K; Nakamori M; Ueda K; Iwahashi M; Ueno H; Muragaki Y; Ooshima A; Yamaue H
    Surgery; 2006 Apr; 139(4):563-73. PubMed ID: 16627068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous transfer of vascular endothelial growth factor and hepatocyte growth factor genes effectively promotes liver regeneration after hepatectomy in cirrhotic rats.
    Oe H; Kaido T; Furuyama H; Mori A; Imamura M
    Hepatogastroenterology; 2004; 51(60):1641-7. PubMed ID: 15532795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor gene therapy of liver cirrhosis in rats.
    Ueki T; Kaneda Y; Tsutsui H; Nakanishi K; Sawa Y; Morishita R; Matsumoto K; Nakamura T; Takahashi H; Okamoto E; Fujimoto J
    Nat Med; 1999 Feb; 5(2):226-30. PubMed ID: 9930873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes.
    Lin Y; Xie WF; Chen YX; Zhang X; Zeng X; Qiang H; Chen WZ; Yang XJ; Han ZG; Zhang ZB
    Liver Int; 2005 Aug; 25(4):796-807. PubMed ID: 15998431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats.
    Yue HY; Yin C; Hou JL; Zeng X; Chen YX; Zhong W; Hu PF; Deng X; Tan YX; Zhang JP; Ning BF; Shi J; Zhang X; Wang HY; Lin Y; Xie WF
    Gut; 2010 Feb; 59(2):236-46. PubMed ID: 19671543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy.
    Salgado S; Garcia J; Vera J; Siller F; Bueno M; Miranda A; Segura A; Grijalva G; Segura J; Orozco H; Hernandez-Pando R; Fafutis M; Aguilar LK; Aguilar-Cordova E; Armendariz-Borunda J
    Mol Ther; 2000 Dec; 2(6):545-51. PubMed ID: 11124055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transduction with a simian virus 40 vector encoding insulin-like growth factor I reduces hepatic damage and the development of liver cirrhosis.
    Vera M; Sobrevals L; Zaratiegui M; Martinez L; Palencia B; Rodríguez CM; Prieto J; Fortes P
    Gene Ther; 2007 Feb; 14(3):203-10. PubMed ID: 17024107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor gene transfer into the liver via the portal vein using electroporation attenuates rat liver cirrhosis.
    Matsuno Y; Iwata H; Umeda Y; Takagi H; Mori Y; Kosugi A; Matsumoto K; Nakamura T; Hirose H
    Gene Ther; 2003 Sep; 10(18):1559-66. PubMed ID: 12907947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in gene therapy of liver cirrhosis].
    Yang R; Gao J
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):30-4. PubMed ID: 15127594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase-type plasminogen activator gene therapy in liver cirrhosis is mediated by collagens gene expression down-regulation and up-regulation of MMPs, HGF and VEGF.
    Bueno M; Salgado S; Beas-Zárate C; Armendariz-Borunda J
    J Gene Med; 2006 Nov; 8(11):1291-9. PubMed ID: 16958060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation.
    Atta HM; Al-Hendy A; Salama SA; Shaker OG; Hammam OA
    Liver Int; 2009 Aug; 29(7):1022-30. PubMed ID: 19515220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion.
    Garcia-Bañuelos J; Siller-Lopez F; Miranda A; Aguilar LK; Aguilar-Cordova E; Armendariz-Borunda J
    Gene Ther; 2002 Jan; 9(2):127-34. PubMed ID: 11857071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tri-iodothyronine and a deleted form of hepatocyte growth factor act synergistically to enhance liver proliferation and enable in vivo retroviral gene transfer via the peripheral venous system.
    Forbes SJ; Themis M; Alison MR; Shiota A; Kobayashi T; Coutelle C; Hodgson HJ
    Gene Ther; 2000 May; 7(9):784-9. PubMed ID: 10822305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Persectives on postgenome medicine: Gene therapy for liver cirrhosis].
    Ueki T; Okamoto E; Takeuchi M; Fujimoto J
    Nihon Rinsho; 2001 Jan; 59(1):152-6. PubMed ID: 11197847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High volume hydrodynamic injection of plasmid DNA via the hepatic artery results in a high level of gene expression in rat hepatocellular carcinoma induced by diethylnitrosamine.
    Tada M; Hatano E; Taura K; Nitta T; Koizumi N; Ikai I; Shimahara Y
    J Gene Med; 2006 Aug; 8(8):1018-26. PubMed ID: 16779866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversing liver cirrhosis: impact of gene therapy for liver cirrhosis.
    Fujimoto J; Kaneda Y
    Gene Ther; 1999 Mar; 6(3):305-6. PubMed ID: 10435078
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene therapy for hepatic fibrosis-bringing treatment into the new millennium.
    Rockey DC
    Hepatology; 1999 Sep; 30(3):816-8. PubMed ID: 10462392
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of CCl4 induced chronic liver injury with bone marrow mesenchymal stem cells overexpressing hepatocyte growth factor].
    Wang LS; Duan HF; Hu JW; Zhang QW; Wang H; Lu ZZ; Wu ZZ; Wang LS
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):934-6. PubMed ID: 16381645
    [No Abstract]   [Full Text] [Related]  

  • 20. Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats.
    Kusumoto K; Ido A; Moriuchi A; Katsura T; Kim I; Takahama Y; Numata M; Kodama M; Hasuike S; Nagata K; Uto H; Inui K; Tsubouchi H
    Int J Mol Med; 2006 Mar; 17(3):503-9. PubMed ID: 16465399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.